Research location

Aurora

Colorado, United States

Published trials2,302

Site observations2,566

Linked trials published2,302

Page1 / 47

Research activity in Aurora

Colorado, United States

CureCurrent currently publishes aggregate city-level research activity for this location: 2,302 trials and 2,566 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Aurora

2,302 linked trials · page 1 of 47

Liver Transplantation From Donors With HIV: Impact on Opportunistic Infections, Cancer, and Long-Term Outcomes (Expanding HOPE Liver)NCT07665372 · 2026-11-01 · 1 site observation

SMART 2D: Study of Montelukast's Effects on Renal and Cardiovascular Health in Adolescents and Young Adults With Type 2 DiabetesNCT07409714 · 2026-10-12 · 1 site observation

Evaluation of MiniMed Next Generation Extended Wear Sensors and Algorithm in Patients With Type 1 and Type 2 DiabetesNCT07864168 · 2026-10-01 · 2 site observations

A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast CancerNCT07701941 · 2026-09-17 · 1 site observation

Exercise Effects on the Neurobiology Underlying Stress-related Eating Behaviors in VeteransNCT06627569 · 2026-09-15 · 1 site observation

A Study of BMS-986528 in Participants With Refractory Rheumatoid ArthritisNCT07412704 · 2026-09-15 · 1 site observation

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose WeightNCT07720271 · 2026-08-31 · 1 site observation

An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)NCT06996652 · 2026-08-17 · 1 site observation

Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATGNCT07216391 · 2026-07-29 · 1 site observation

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)NCT07492680 · 2026-07-27 · 1 site observation

Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued TreatmentNCT07444567 · 2026-07-24 · 1 site observation

App-Based Certified Diabetes Education Therapy (AB-CDE)NCT07282639 · 2026-07-08 · 1 site observation

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background InsulinNCT07664553 · 2026-07-08 · 1 site observation

Small Trial of Alendronate Impact on the Reservoir of HIVNCT07216794 · 2026-07-08 · 1 site observation

To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of TreatmentNCT07684820 · 2026-06-30 · 1 site observation

Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in Pregnancy in Women With Hepatitis C With and Without HIVNCT07040319 · 2026-06-25 · 1 site observation

A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic DysfunctionNCT07192952 · 2026-06-01 · 1 site observation

A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose WeightNCT07564414 · 2026-05-21 · 1 site observation

Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes MellitusNCT07142252 · 2026-05-14 · 1 site observation

Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 SystemNCT07579702 · 2026-05-13 · 1 site observation

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and ObesityNCT07567001 · 2026-05-11 · 2 site observations

Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)NCT07318597 · 2026-05-06 · 1 site observation

A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)NCT07513376 · 2026-05-04 · 1 site observation

The EASE Study: Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced CancerNCT07636200 · 2026-05-04 · 1 site observation

AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)NCT07611110 · 2026-05-04 · 1 site observation

An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)NCT07365332 · 2026-04-23 · 1 site observation

A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILDNCT07285655 · 2026-04-23 · 1 site observation

A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate CancerNCT07365995 · 2026-04-22 · 1 site observation

Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes MellitusNCT06964087 · 2026-04-10 · 1 site observation

Menopausal HT for Women Living With HIV (HoT)NCT06856174 · 2026-04-09 · 1 site observation

Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the LungNCT07499674 · 2026-03-31 · 1 site observation

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL TrialNCT07200830 · 2026-03-31 · 1 site observation

A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 AsthmaNCT07456033 · 2026-03-13 · 1 site observation

A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLCNCT07491497 · 2026-03-11 · 1 site observation

Adapting rHIRE and Sleep Monitoring in Parkinson's DiseaseNCT07498296 · 2026-03-05 · 1 site observation

Snacking Effects on the Brain Response to Foods and Satiety During DietingNCT07428187 · 2026-03-05 · 1 site observation

Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United StatesNCT07293559 · 2026-02-24 · 1 site observation

REVEAL Study - Diagnostic Testing for PTSD Using the Senseye Diagnostic ToolNCT07280065 · 2026-02-23 · 1 site observation

A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)NCT07202546 · 2026-02-11 · 1 site observation

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or OverweightNCT07369011 · 2026-02-10 · 1 site observation

A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)NCT07222332 · 2026-02-05 · 1 site observation

INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 DiabetesNCT07224321 · 2026-02-04 · 1 site observation

Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced CancersNCT07227298 · 2026-01-30 · 1 site observation

A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)NCT07227597 · 2026-01-29 · 1 site observation

A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic AsthmaNCT07323654 · 2026-01-28 · 1 site observation

Primary Care Pragmatic, Real World Experience for Automated Insulin DeliveryNCT07011147 · 2026-01-16 · 1 site observation

Targeted Telerehabilitation Following Curative Intent Therapy of Lung CancerNCT05179408 · 2026-01-12 · 1 site observation

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate CancerNCT07225946 · 2025-12-19 · 1 site observation

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon MutationsNCT07185997 · 2025-12-17 · 1 site observation

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 DiabetesNCT07282600 · 2025-12-15 · 1 site observation

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.